Tuesday , November 5 2024
Home / Mike Norman Economics / Rod Tucker PhD – Chloroquine in severe COVID-19: reviewing the evidence

Rod Tucker PhD – Chloroquine in severe COVID-19: reviewing the evidence

Summary:
At the beginning of treatment high dose Chloroquine seemed to save lives, but in later stages fatality rates went up. The trail in this experiment was halted early because of the dangers.  While this trial was interrupted at an early stage, the results should be seen as a warning that chloroquine (and probably hydroxychloroquine) are not the purported wonder drugs for those with COVID-19. Rod Tucker BPharm PhD  Chloroquine in severe COVID-19: reviewing the evidence

Topics:
Mike Norman considers the following as important:

This could be interesting, too:

Jodi Beggs writes Economists Do It With Models 1970-01-01 00:00:00

Mike Norman writes 24 per cent annual interest on time deposits: St Petersburg Travel Notes, installment three — Gilbert Doctorow

Lars Pålsson Syll writes Daniel Waldenströms rappakalja om ojämlikheten

Merijn T. Knibbe writes ´Fryslan boppe´. An in-depth inspirational analysis of work rewarded with the 2024 Riksbank prize in economic sciences.

At the beginning of treatment high dose Chloroquine seemed to save lives, but in later stages fatality rates went up. The trail in this experiment was halted early because of the dangers. 


While this trial was interrupted at an early stage, the results should be seen as a warning that chloroquine (and probably hydroxychloroquine) are not the purported wonder drugs for those with COVID-19.

Rod Tucker BPharm PhD 

Mike Norman
Mike Norman is an economist and veteran trader whose career has spanned over 30 years on Wall Street. He is a former member and trader on the CME, NYMEX, COMEX and NYFE and he managed money for one of the largest hedge funds and ran a prop trading desk for Credit Suisse.

Leave a Reply

Your email address will not be published. Required fields are marked *